Deep Medical Therapeutics is a medical technology company that builds and deploys artificial intelligence (AI) solutions that empower medical practitioners to treat antimicrobial resistance.
WHAT IS ANTIMICROBIAL RESISTANCE
Antimicrobial resistance (AMR) occurs when disease-causing micro-organisms, such as bacteria, fungi, viruses, and parasites, no longer respond to the antibiotics designed to treat them.
The global incidence of these drug-resistant micro-organisms, often referred to as “superbugs”, is on the increase and poses one of the greatest threats to human health. According to the WHO, patients with infections caused by drug-resistant microbes have poorer treatment outcomes and consume more health-care resources than patients infected with non-resistant strains.
Micro-organisms often undergo genetic mutations that alter their response to certain antibiotics, therefore, enabling them to continue thriving in the presence of these drugs. The inadequate diagnosis and treatment of these microbial strains further exasperate the occurrence of AMR, rendering the limited treatment options ineffective.
Deep Medical Therapeutics aims to solve this challenge by harnessing the power of machine learning and genetic data for the identification and treatment of drug-resistant microbial strains.
Our technology is based on an artificially intelligent software platform that uses genetic data from the host and micro-organism, machine learning algorithims and accessible smartphone technology for the identification and treatment of the drug-resistant microbial strains.